Cytotoxicity of artemisinin, a dimer of dihydroartemisinin, artemisitene and eupatoriopicrin as evaluated by the MTT and clonogenic assay

Phytotherapy Research

Volumn 10, Issue 2, 1996, Pages 140-144

  Beekman, Aäron C ^a   Woerdenbag, Herman J ^a   Kampinga, Harm H ^a   Konings, Antonius W T ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Artemisinin; Clonogenic assay; Cytotoxicity; MTT assay; Sesquiterpene lactones

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; ARTEMISININ; ARTEMISITENE; CISPLATIN; DIHYDROARTEMISININ DERIVATIVE; DIMER; DOXORUBICIN; EUPATORIOPICRIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL DEATH; CELL KILLING; CLONOGENIC ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; EHRLICH ASCITES TUMOR CELL; HELA CELL; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MOUSE; NONHUMAN;

EID: 0029979290     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1573(199603)10:2<140::AID-PTR792>3.0.CO;2-D     Document Type: Article

References (20)

1. Bellamy, W. T. (1992). Prediction of response to drug therapy of cancer - a review of in vitro assays. Drugs 44, 690-708.
2. Carmichael, J., DeGraff, W. G., Gazdar, A. F., Minna, J. D., and Mitchell, J. B. (1987). Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47, 936-942.
3. Hettinga, J. V. E., Lemstra, W., Meijer, C. et al. (1994). Hyperthermic potentiation of cisplatin toxicity in a human small cell lung carcinoma cell line and a cisplatin resistant subline. Int. J. Hyperthermia 10, 795-805.
4. Jorritsma, J. B. M., and Konings, A. W. T. (1983). Inhibition of repair of radiation-induced strand breaks by hyperthermia and its relationship to cell survival after hyperthermia alone. Int. J. Radiat. Biol. 43, 506-516.
5. Kamchonwongpaisan, S., Vanitchareon, N., and Yuthavong, Y. (1992). The mechanism of antimalarial action of artemisinin (qinghaosu). In, Lipid-soluble Antioxidants: Biochemistry and Clinical Applications, ed. by A. S. H. Ong and L. Packer, pp. 363-372. Birkhaüser Verlag, Basel.
6. Klayman, D. L. (1985). Qinghaosu (artemisinin): an antimalarial drug from China. Science 228, 1049-1055.
7. Konings, A. W. T., Hettinga, J. V. E., Lemstra, W., Humphrey, G. B., and Kampinga, H. H., (1993). Sensitizing for cisdiamminedichloroplatinum(ll) action by hyperthermia in resistant cells. Int. J. Hyperthermia 9, 553-555.
8. Krungkrai, S. R., and Yuthavong, Y. (1987). The antimalarial action of Plasmodium falciparum of qinghaosu and artesunate in combination with agents which modulate oxidant stress. Trans. R. Soc. Trop. Med. Hyg. 81, 710-714.
9. Kupchan, S. M., Eakin, M. A., and Thomas, A. M. (1971). Tumor inhibitors. 69. Structure-cytotoxicity relationships among the sesquiterpene lactones. J. Med. Chem. 14, 1147-1152.
10. Meshnick, S. R., Yang, Y. Z., Lima, V., Kuypers, F., Kamchonwongpaisan, S., and Yuthavong, Y. (1993). Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob. Agents Chemother. 37, 1108-1114.
11. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Methods 65, 55-63.
12. Page, M., Bejaoui, N., Cinq-mars, B., and Lemieux, P. (1988). Optimization of the tetrazolium-based colorimetric assay for the measurement of cell number and cytotoxicity. Int. J. Immunopharmacol. 10, 785-793.
13. Plumb, J. A., Milroy, R., and Kaye, S. B. (1989). Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res. 49, 4435-4440.
14. Rosenfeld, C. S. (1992). Potential of phenylalanine methylester as a bone marrow purging agent. Blood 80, 2401-2405.
15. Ruben, R. L., and Neubauer, R. H. (1987). Semiautomated colorimetric assay for in vitro screening of anticancer compounds. Cancer Treat Rep. 71, 1141-1149.
16. Wasserman, L., Aviram, R., Lehavi, H. et al. (1992). A cell line with unusual characteristics from an ovarian carcinoma patient: modulation of sensitivity to antitumour drugs. Eur. J. Cancer 28, 22-27.
17. Watts, M. E., Roberts, I. J., and Woodcock, M. W. (1989). A comparison of colorimetric and clonogenic assays for hypoxic-specific toxins with hamster and human cells. Int. J. Radiat. Oncol. Biol. Phys. 16, 939-942.
18. Woerdenbag, H. J., Lemstra, W., Malingre, T. M., and Konings, A. W. T. (1989). Enhanced cytostatic activity of thesesquiterpene lactone eupatoriopicrin by glutathione depletion. Br. J. Cancer 59, 68-75.
19. Woerdenbag, H. J., Moskal, T. A., Pras, N. et al. (1993). Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells. J. Nat. Prod. 56, 849-856.
20. Woerdenbag, H. J., Pras, N., van Uden, W., Wallaart, T. E., Beekman, A. C., and Lügt, C. B. (1994). Progress in the research of artemisinin-related antimalarials: an update. Pharm. World Sci. 16, 169-180.